3SJ-14198-89079
5 vaccinations
4 coded responses
42 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 370 / TN
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-13
Dose 1 — Pfizer-BioNTech
-
2021-02-15
Registered in v-safe
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-06
Dose 2 — Pfizer-BioNTech
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Skin lesion — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Three red lesions. One bullseye. 2 are on back of shoulder. One near collarbone on side of injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Injection site joint erythema, Injection site swelling — Feeling: GoodFree text: The 3 flat lesions reported yesterday, on shoulder but not site of injection, are better. Less red and swollen. Seem to be ckearing up with use of over the counter antibiotic cream.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — days 1–6 daily, dose 2MedDRA: Skin lesion — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: The 3 red lesions on left shoulder, not at injection site, continue to heal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — day 7, dose 2MedDRA: Urticaria — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: 3 areas I would now describe as hives are still clearing up.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2022-03-06
-
2022-05-09
Dose 4 — Pfizer-BioNTech
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-15
- 2022-05-16
- 2022-05-25
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-06-20
- 2022-08-09
-
2022-09-24
Dose 5 — Pfizer-BioNTech
- 2022-10-16
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-12-24
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-05-09 | Pfizer-BioNTech | No |
| 5 | 2022-09-24 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Three red lesions. One bullseye. 2 are on back of shoulder. One near collarbone on side of injection.
Systemic reaction (other): The 3 flat lesions reported yesterday, on shoulder but not site of injection, are better. Less red and swollen. Seem to be ckearing up with use of over the counter antibiotic cream.
Systemic reaction (other): The 3 red lesions on left shoulder, not at injection site, continue to heal.
Release 5 — day 7, dose 2
Systemic reaction (other): 3 areas I would now describe as hives are still clearing up.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site joint erythema | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Skin lesion | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release